Literature DB >> 36263105

Late Cardiac Antibody-Mediated Rejection: A Only Heart Duel.

Catarina Costa1, Ana Filipa Amador1, João Calvão1, Roberto Pinto1,2, Pedro Rodrigues Pereira3, José Pinheiro Torres4, Sandra Amorim1,2, Filipe Macedo1,2.   

Abstract

Entities:  

Year:  2022        PMID： 36263105      PMCID： PMC9383344          DOI： 10.36628/ijhf.2021.0027

Source DB:  PubMed          Journal:  Int J Heart Fail        ISSN： 2636-154X


× No keyword cloud information.
  9 in total

1.  The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.

Authors:  Maria Rosa Costanzo; Anne Dipchand; Randall Starling; Allen Anderson; Michael Chan; Shashank Desai; Savitri Fedson; Patrick Fisher; Gonzalo Gonzales-Stawinski; Luigi Martinelli; David McGiffin; Jon Smith; David Taylor; Bruno Meiser; Steven Webber; David Baran; Michael Carboni; Thomas Dengler; David Feldman; Maria Frigerio; Abdallah Kfoury; Daniel Kim; Jon Kobashigawa; Michael Shullo; Josef Stehlik; Jeffrey Teuteberg; Patricia Uber; Andreas Zuckermann; Sharon Hunt; Michael Burch; Geetha Bhat; Charles Canter; Richard Chinnock; Marisa Crespo-Leiro; Reynolds Delgado; Fabienne Dobbels; Kathleen Grady; W Kao; Jaqueline Lamour; Gareth Parry; Jignesh Patel; Daniela Pini; Jeffrey Towbin; Gene Wolfel; Diego Delgado; Howard Eisen; Lee Goldberg; Jeff Hosenpud; Maryl Johnson; Anne Keogh; Clive Lewis; John O'Connell; Joseph Rogers; Heather Ross; Stuart Russell; Johan Vanhaecke
Journal:  J Heart Lung Transplant       Date:  2010-08       Impact factor: 10.247

2.  Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.

Authors:  D A Baran; S Lubitz; S Alvi; J T Fallon; S Kaplan; I Galin; R Correa; M C Courtney; M Chan; D Spielvogel; S L Lansman; A L Gass
Journal:  Transplant Proc       Date:  2004-12       Impact factor: 1.066

3.  Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.

Authors:  Guillaume Coutance; Salima Ouldamar; Philippe Rouvier; Samir Saheb; Caroline Suberbielle; Nicolas Bréchot; Sarah Hariri; Guillaume Lebreton; Pascal Leprince; Shaida Varnous
Journal:  J Heart Lung Transplant       Date:  2015-03-20       Impact factor: 10.247

4.  Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association.

Authors:  Monica M Colvin; Jennifer L Cook; Patricia Chang; Gary Francis; Daphne T Hsu; Michael S Kiernan; Jon A Kobashigawa; JoAnn Lindenfeld; Sofia Carolina Masri; Dylan Miller; John O'Connell; E Rene Rodriguez; Bruce Rosengard; Sally Self; Connie White-Williams; Adriana Zeevi
Journal:  Circulation       Date:  2015-04-02       Impact factor: 29.690

5.  A survey of current practice for antibody-mediated rejection in heart transplantation.

Authors:  S Chih; K J Tinckam; H J Ross
Journal:  Am J Transplant       Date:  2013-02-15       Impact factor: 8.086

6.  Treatment of vascular rejection with rituximab in cardiac transplantation.

Authors:  H Edward Garrett; Denise Duvall-Seaman; Beth Helsley; Kenneth Groshart
Journal:  J Heart Lung Transplant       Date:  2005-09       Impact factor: 10.247

Review 7.  Immunosuppression following heart transplantation: prospects and challenges.

Authors:  David H Chang; Michelle M Kittleson; Jon A Kobashigawa
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

8.  The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection.

Authors:  Kevin J Clerkin; Susan W Restaino; Emmanuel Zorn; Elena R Vasilescu; Charles C Marboe; Donna M Mancini
Journal:  J Heart Lung Transplant       Date:  2016-05-06       Impact factor: 10.247

9.  Rituximab is associated with improved survival in cardiac allograft patients with antibody-mediated rejection: a single center review.

Authors:  Ashwin K Ravichandran; Joel D Schilling; Eric Novak; John Pfeifer; Gregory A Ewald; Susan M Joseph
Journal:  Clin Transplant       Date:  2013-11-09       Impact factor: 2.863
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.